Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Non-cash Items (2018 - 2024)

Serina Therapeutics' Non-cash Items history spans 6 years, with the latest figure at $80000.0 for Q4 2023.

  • For Q4 2023, Non-cash Items rose 4605.88% year-over-year to $80000.0; the TTM value through Dec 2023 reached $80000.0, up 4605.88%, while the annual FY2023 figure was $80000.0, 4605.88% up from the prior year.
  • Non-cash Items for Q4 2023 was $80000.0 at Serina Therapeutics, down from $3.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.1 million in Q3 2023 and bottomed at $1700.0 in Q4 2022.
  • The 5-year median for Non-cash Items is $1.9 million (2020), against an average of $1.5 million.
  • The largest annual shift saw Non-cash Items crashed 99.0% in 2019 before it surged 4605.88% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $13000.0 in 2019, then skyrocketed by 1738.46% to $239000.0 in 2020, then plummeted by 55.23% to $107000.0 in 2021, then plummeted by 98.41% to $1700.0 in 2022, then soared by 4605.88% to $80000.0 in 2023.
  • Per Business Quant, the three most recent readings for SER's Non-cash Items are $80000.0 (Q4 2023), $3.1 million (Q3 2023), and $3.0 million (Q2 2023).